N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors
- 15 March 2009
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (6), 1745-1748
- https://doi.org/10.1016/j.bmcl.2009.01.084
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Fatty acid-binding proteins: role in metabolic diseases and potential as drug targetsNature Reviews Drug Discovery, 2008
- Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP)Bioorganic & Medicinal Chemistry Letters, 2007
- Inflammation and metabolic disordersNature, 2006
- NMR Structure of a Potent Small Molecule Inhibitor Bound to Human Keratinocyte Fatty Acid-Binding ProteinJournal of Medicinal Chemistry, 2006
- A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular diseaseProceedings of the National Academy of Sciences, 2006
- Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: a novel class of selective human A-FABP inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes targetBioorganic & Medicinal Chemistry Letters, 2004
- Improved Glucose and Lipid Metabolism in Genetically Obese Mice Lacking aP2Endocrinology, 2000
- Structural and functional features of different types of cytoplasmic fatty acid-binding proteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Tissue specific expression of p422 protein, a putative lipid carrier, in mouse adipocytesBiochemical and Biophysical Research Communications, 1985